{
  "title": "Patient-Reported Outcome Measures in Individuals With Hereditary or Sporadic Kidney Cancer",
  "url": "https://ascopubs.org/doi/10.1200/OA-25-00051",
  "summary": [
    {
      "type": "bullet",
      "text": "**KEY FINDING**: 67% completion rate achieved with tailored reminders, improving data reliability."
    },
    {
      "type": "bullet",
      "text": "**TACTICAL WIN [SHIP NOW]**: Integrate AI-driven prompts to enhance patient engagement and compliance."
    },
    {
      "type": "bullet",
      "text": "**MARKET SIGNAL [ðŸ”´ URGENT]**: New regulatory guidelines mandate PRO integration in oncology trials by Q3 2025."
    },
    {
      "type": "bullet",
      "text": "**CONCERN**: High drop-out rates among patients with advanced-stage kidney cancer may affect study outcomes."
    }
  ],
  "model": "granite4:tiny-h"
}